BioCeuticals NuroSAMe Plus 60t

Description

NeuroSAMe Plus contains 200mg of S-adenosylmethionine (SAMe) and vitamin cofactors to assist in the maintenance of healthy mood. SAMe, folinic acid (bioactivated vitamin B9) and vitamin B12 play a role in the synthesis of important neurotransmitters such as dopamine and serotonin. Vitamin B12 and folinic acid are also important cofactors for the synthesis of SAMe within the body.

Features:

• Helps maintain healthy mood by naturally increasing dopamine and serotonin levels.
• May assist in the management of medically diagnosed fibromyalgia, providing symptomatic relief from pain, fatigue and mood swings at 600-800mg of SAMe a day.
• Contains the active form of folic acid - folinic acid.
• Vitamin B12 and folic acid may assist in the maintenance of normal healthy memory function.
• Supports healthy liver function.
• Supports normal healthy homocysteine levels.
• Provides antioxidant support by contributing to glutathione production.
• May reduce inflammation and improve joint mobility associated with mild arthritis.
• Helps maintain normal blood and form red blood cells.
• B12 and folic acid are involved in the production of SAMe in the body.
• May help to maintain the health of vegetarians who are at risk of vitamin B12 insufficiency.
• Enteric-coated tablets, suitable for vegans.
  

 

Each enteric-coated tablet contains:
Ademetionine disulfate tosylate	412.37mg
equiv. ademetionine (SAMe)	200mg
equiv. (S)-S-adenosylmethionine	147.0mg
Calcium folinate	173.6mcg
equiv. folinic acid (activated vitamin B9)	125mcg
Cyanocobalamin (vitamin B12)	50mcg

 

No added dairy, gluten, shellfish, soy protein, yeast.

Vegan and vegetarian friendly.

• Individuals who are using prescription antidepressants or suffer from bipolar depression should not use this product unless under the supervision of a healthcare practitioner.
• If symptoms persist, consult your healthcare practitioner.
• Vitamin supplements should not replace a balanced diet.
• Always read the label. Use only as directed.

Prescribing Information:

• SAMe has been used intravenously in the last trimester of pregnancy with no adverse effects to mother or foetus. However, safety has not yet been conclusively established for either injectable or oral dose forms and possible effects on prolactin levels need to be considered.
• Not to be used by individuals who are using prescription antidepressants. Theoretically, co-administration may result in an increased risk of serotonin syndrome.
• SAMe should be avoided in people with bipolar disorder and used with caution by people with schizophrenia or schizoaffective disorder, or Parkinson's disease.
• SAMe methylates levodopa, which could theoretically reduce the effectiveness of levodopa given for Parkinson's disease; however, the effect has not been observed clinically.